Nefrosave Global

Global Prevalence of Microalbuminuria on the Rise!

Global Microalbuminuria Map
01UAE61%
02Nepal57.7%
03India46%
04United States44%
05Ghana43%
06Sri Lanka36%
07Myanmar35%
08Malaysia34.4%
09Nigeria>34%
10Kenya32.7%
11Qatar28.2%
12Oman27%
13UK24.9%
14Cameroon14.2%
15Europe12.6%
16Tanzania10.7%
17Canada10.3%
Scientific References

1. UAE — BMC Nephrology, 2008

2. Nepal — Medicine (Baltimore). 2025 Jun 27;104(26):e43075.

3. India — Indian Journal of Nephrology, 2008

4. United States — American Society of Nephrology, 2007

5. Ghana — Ethnicity & Disease. 2007 Autumn;17(4):726-30

6. Sri Lanka — Sri Lankan Family Physician, 2018

7. Myanmar — Myanmar Health Sciences Research Journal, Vol. 30, No. 2, 2018

8. Malaysia — Malaysian Family Physician. 2022 Aug 25;17(3):53–63

9. Nigeria — IMAN Medical Journal, Vol. 11 No. 2, 2025

10. Kenya — Kidney International, 2003

11. Qatar — Cureus. DOI: 10.7759/cureus.45854

12. Oman — Kidney International, 2001

13. UK — Diabetes Research and Clinical Practice, 2006

14. Cameroon — BMC Research Notes. 2017 Sep 12;10(1):477

15. Europe — BMC Nephrology, 2020

16. Tanzania — BMC Nephrology, 2007

17. Canada — Canadian Medical Association Journal, 2013

NEFROSAVE Combination Available Globally as

Nefrosave Global Reach Map
Nefrosave Center Graphic

Nefrosave

Nepal, Sri Lanka, Oman, Qatar, Uzbekistan, Malawi

Nefrosave Plus

Kenya, Ghana

Albunil

Myanmar, UAE

Nefrosave Global

Global Prevalence of Microalbuminuria

NEFROSAVE Combination Available Globally as